TheraRadar

Pharma Intelligence, Simplified

Landscape → CNS

Opioid Use Disorder

365 clinical trials

134 active
/
365 total (since 2015)
25
Phase 1 Active
77 total
57
Phase 2 Active
132 total
29
Phase 3 Active
73 total
37
Phase 4 Active
120 total

Top Sponsors (Industry)

Sorted by active Active Done Failed
Indivior Inc. 1 14 0
Go Medical Industries Pty Ltd 1 2 0
Akyso Therapeutics, LLC 1 1 0
Eli Lilly 1 0 0
Boehringer Ingelheim 1 0 0
Inventage Lab., Inc. 1 0 0
Boulder Care 1 0 0
Sonara Health 1 0 0
Proniras Corporation 1 0 0
Filament Health Corp. 1 0 0
Evon Medics LLC 1 0 0
Braeburn Pharmaceuticals 0 4 0
AstraZeneca 0 2 1
Astellas Pharma Global Development, Inc. 0 2 1
NCT05033028 RECRUITING
Smartphones for Opiate Addiction Recovery
NYU Langone Health n=225
NCT06077422 ENROLLING BY INVITATION
Exparel vs. Marcaine ESP Block for Post-cardiac Surgical Pain
Rutgers, The State University of New Jersey n=150
NCT07148206 NOT YET RECRUITING
Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial
Montefiore Medical Center n=40
NCT05459402 RECRUITING
Divided or Single Exposure (DOSE) Study
University of Maryland, Baltimore n=150
NCT06306443 RECRUITING
Buprenorphine for Individuals in Jail
Friends Research Institute, Inc. n=240
NCT07361432 NOT YET RECRUITING
Digital Treatment for Chronic Pain and Addiction in Veterans With Opioid Use Disorder Receiving Buprenorphine
VA Office of Research and Development n=250
NCT04408313 ACTIVE NOT RECRUITING
Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail
Friends Research Institute, Inc. n=240
NCT05058287 RECRUITING
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
Hospital for Special Surgery, New York n=150
NCT07296770 NOT YET RECRUITING
An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service
University of California, San Francisco n=126
NCT05766631 RECRUITING
Treating Polysubstance Use Using a Novel Digital Technology
Friends Research Institute, Inc. n=240
NCT06940674 RECRUITING
Adjunctive Cannabidiol for Recovery From Opioid Study
Icahn School of Medicine at Mount Sinai n=450
NCT04452344 ACTIVE NOT RECRUITING
Opioid Analgesic Reduction Study
Rutgers, The State University of New Jersey n=1,815
NCT05597878 RECRUITING
Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy
Wake Forest University Health Sciences n=100
NCT05589181 RECRUITING
High Dose Buprenorphine (BUP) Induction in the Emergency Department (ED)
Rutgers, The State University of New Jersey n=140
NCT06316830 RECRUITING
Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose
Rhode Island Hospital n=250
NCT03823534 RECRUITING
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
St. Louis University n=60
NCT05790252 RECRUITING
Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE)
Washington University School of Medicine n=40
NCT06032559 RECRUITING
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
Rutgers, The State University of New Jersey n=450
NCT04893525 RECRUITING
Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments
University of British Columbia n=658
NCT05011266 RECRUITING
Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
New York State Psychiatric Institute n=180
NCT06494904 RECRUITING
Standard Versus High Dose ED-Initiated Buprenorphine Induction
Yale University n=360
NCT04365920 ACTIVE NOT RECRUITING
Recovery Management Checkups for Opioid Use Disorder Experiment
Chestnut Health Systems n=455
NCT05834478 RECRUITING
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Emory University n=103
NCT06033599 RECRUITING
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement
Rutgers, The State University of New Jersey n=420
NCT06089707 RECRUITING
Behavioral Pharmacological Examination of a Novel Buprenorphine Induction Method Among Individuals Who Use Fentanyl
Johns Hopkins University n=25
NCT05283980 ACTIVE NOT RECRUITING
Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement
Beth Israel Deaconess Medical Center n=62
NCT05120076 RECRUITING
Perioperative Dexamethasone Reduces Postoperative Pain and Nausea After Periacetabular Osteotomy
Balgrist University Hospital n=60
NCT05930184 RECRUITING
Laparoscopic Guided Peri-wound Transversus Abdominis Plane Block With Bupivacaine Versus Local Wound Infiltration on Post-op Opioid Use in Laparoscopic Sleeve Gastrectomy
Khon Kaen University n=98
NCT03345173 ACTIVE NOT RECRUITING
Facilitating Rapid Naltrexone Initiation
New York State Psychiatric Institute n=100
NCT04655339 WITHDRAWN
Laparoscopic Transversus Abdominis Plane (TAP) Block to Reduce Post-operative Opioids
Baylor Research Institute
NCT04325659 COMPLETED
An Innovative Intervention for OUD Treatment
Johns Hopkins University n=46
NCT03616236 SUSPENDED
Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment
Friends Research Institute, Inc. n=320
NCT05153785 COMPLETED
Perioperative Intravenous Lidocaine in Liver Surgery
Lund University Hospital n=124
NCT05152134 COMPLETED
Mobile & Online-Based Interventions to Lessen Pain
Stanford University n=234
NCT04345718 COMPLETED
EXHIT ENTRE Comparative Effectiveness Trial
Gavin Bart n=344
NCT07092475 WITHDRAWN
The Impact of Intraoperative Methadone on Postoperative Opioid Use
University of Utah
NCT04122196 COMPLETED
Perioperative Pregabalin in Ureteroscopy
University of Missouri-Columbia n=118
NCT04759703 TERMINATED
Treatment of Restless Legs Symptoms With Pramipexole to Improve the Outcomes of Protracted Opioid Withdrawal in OUD
Massachusetts General Hospital n=75
NCT04588389 TERMINATED
Comparison of Quadratus Lumborum Block Types
University of Massachusetts, Worcester n=9
NCT05386069 COMPLETED
Does a Non-Opioid Multimodal Pain (NOMO) Protocol Decrease Narcotic Use
Prisma Health-Upstate n=10
NCT04081545 COMPLETED
Effect of Opioid Free Anesthetic on Post-Operative Opioid Consumption After Laparoscopic Bariatric Surgery
Christine Oryhan n=181
NCT04443569 COMPLETED
Lidocaine Patches After Cesarean Section
Yale University n=93
NCT06522633 COMPLETED
Esophageal Dysfunction Associated With Opioids: Clinical Response and Manometric Findings After Opioid Discontinuation
Hospital Clinic of Barcelona n=20
NCT03929640 TERMINATED
Management Of Pain After Cesarean Trial
Milton S. Hershey Medical Center n=49
NCT04296396 COMPLETED
Opioid Prescription After Cesarean Trial
The George Washington University Biostatistics Center n=5,521
NCT04610398 COMPLETED
Perioperative Dexamethasone Reduces Postoperative Pain and Nausea After Hip Arthroscopy
Balgrist University Hospital n=60
NCT04556552 COMPLETED
Non-Invasive Vagal Nerve Stimulation in Opioid Use Disorders
Emory University n=20
NCT04622813 COMPLETED
Nonopioid Analgesics and Cholecystectomy
American University of Beirut Medical Center n=90
NCT02187198 COMPLETED
Buprenorphine Treatment for Opioid Dependence
Yale University n=9
NCT02483468 COMPLETED
The Effects of Cognitive Behavioral Therapy and Transcranial Current Stimulation (tDCS) on Chronic Lower Back Pain
Medical University of South Carolina n=160
NCT03232346 COMPLETED
A Strategy to Improve Success of Treatment Discontinuation in Buprenorphine Responders
New York State Psychiatric Institute n=11
NCT04517110 TERMINATED
Perioperative Pregabalin for Reducing Opioid Consumption After Cardiac Surgery
Hamilton Health Sciences Corporation n=17
NCT02696096 COMPLETED
Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence
Butler Hospital n=21
NCT04910165 COMPLETED
Exparel Use in Adductor Canal Block After Total Knee Arthroplasty
St. Luke's Hospital, Pennsylvania n=100
NCT03818399 TERMINATED
Virginia Opioid Overdose Treatment InitiatVE
Virginia Commonwealth University n=19
NCT03275350 COMPLETED
Comparing Treatments for HIV-Infected Opioid Users in an Integrated Care Effectiveness Study (CHOICES) Scale-Up
Oregon Health and Science University n=114
NCT04246541 COMPLETED
Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic Meniscus Surgery
University Hospitals Cleveland Medical Center n=48
NCT03113409 TERMINATED
Buprenorphine as Adjunct to Outpatient Induction Onto Vivitrol
New York State Psychiatric Institute n=10
NCT03586934 WITHDRAWN
Multimodal Analgesia in Shoulder Arthroplasty
Rush University Medical Center
NCT03508830 COMPLETED
Minimally Invasive Thoracic Surgery Intercostal Nerve Block Trial
University of California, San Francisco n=91
NCT03805386 COMPLETED
Patient-Directed Postoperative Opioid Prescribing for Gynecologic Surgery
Mayo Clinic n=65
NCT04523792 WITHDRAWN
Virginia Opioid Treatment-Emergency Department
Virginia Commonwealth University
NCT03169816 COMPLETED
Lorcaserin in Combination With XR-Naltrexone for Relapse Prevention in Opioid Use Disorder
New York State Psychiatric Institute n=60
NCT04197570 COMPLETED
Opioid-free Anesthesia for Open Cardiac Surgery: A Prospective Randomized Controlled Trial
Benaroya Research Institute n=9
NCT02672111 COMPLETED
Long-Term Safety Study of Buprenorphine (CAM2038) in Adult Outpatients With Opioid Use Disorder
Braeburn Pharmaceuticals n=228
NCT02110264 COMPLETED
Injectable Pharmacotherapy for Opioid Use Disorders (IPOD)
University of California, Los Angeles n=151
NCT02651584 COMPLETED
Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence
Braeburn Pharmaceuticals n=428
NCT02502175 COMPLETED
Comparing Opium Tincture (OT) With Methadone for Medication-assisted Treatment of Opioid Use Disorder
University of British Columbia n=204
NCT02537574 COMPLETED
Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)
Alkermes, Inc. n=380
NCT02696434 COMPLETED
Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL
Alkermes, Inc. n=101
NCT02896296 COMPLETED
Open-Label Treatment Extension Study
Indivior Inc. n=208
NCT02510014 COMPLETED
Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder
Indivior Inc. n=775
NCT02357901 COMPLETED
Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine
Indivior Inc. n=665

Data: ClinicalTrials.gov